MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 912938 Boston, MA

Position in BIO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$110,426,810

-$10,528,915 QoQ

Shares Held

396,150

-0.8% QoQ

Ownership

1.48%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 74.60785056165594.ToString("F0")% Shared 20.62955951028651.ToString("F0")% None 4.7625899280575545.ToString("F0")%

Healthcare · as of Mar 31, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,029,179,529 across 17 Medical Devices names. BIO ranks #7 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDT	Medtronic plc	21,437,599	$1,857,567,950
2	ABT	Abbott Laboratories	15,499,870	$1,591,371,647
3	STE	STERIS plc	4,010,349	$886,808,469
4	BSX	Boston Scientific Corp	10,996,572	$690,034,889
5	MASI	Masimo Corp	2,342,790	$416,712,054
6	DXCM	Dexcom Inc	1,934,452	$121,483,582
7	BIO	Bio-Rad Laboratories, Inc. This page	396,150	$110,426,810
8	GEHC	GE HealthCare Technologies Inc.	1,260,998	$89,757,836

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$110,426,810	396,150	-0.8%	Shares	Defined	2026-05-14
2025-12-31	$120,955,725	399,207	+4534.4%	Shares	Sole	2026-01-22
2025-09-30	$2,415,277	8,614	+131.2%	Shares	Sole	2025-10-29
2025-06-30	$899,157	3,726	-12.6%	Shares	Sole	2025-08-08
2025-03-31	$1,038,051	4,262	+18.5%	Shares	Sole	2025-05-02
2024-12-31	$1,181,649	3,597	-93.4%	Shares	Sole	2025-02-12
2024-09-30	$18,121,855	54,163	-84.5%	Shares	Sole	2024-11-12
2024-06-30	$95,189,757	348,540	+0.4%	Shares	Sole	2024-08-09
2024-03-31	$120,104,046	347,252	+7.7%	Shares	Sole	2024-05-14
2023-12-31	$104,065,509	322,294	-0.4%	Shares	Sole	2024-02-08
2023-09-30	$116,036,356	323,717	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.